Northwest Biotherapeutics's total assets for Q2 2025 were $29.55M, an increase of 7.42% from the previous quarter. NWBO total liabilities were $129.94M for the fiscal quarter, a 2.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.